Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Thank you for standing by. My name is Bella, and I will be your ...

Seres Therapeutics Inc. ( (MCRB) ) has released its Q3 earnings. Here is a breakdown of the information Seres Therapeutics Inc. presented to ...

Seres Therapeutics Inc (MCRB) reports promising clinical results and strategic financial maneuvers, despite facing increased ...

Within two days of the election, Newsom positioned himself at the forefront of the opposition, calling for state lawmakers to convene an emergency special session "to safeguard California values" in ...

CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Seres Therapeutics Inc. (MCRB) on Wednesday reported third-quarter earnings of $88.8 million. The Cambridge, Massachusetts-based company said it had ...

Seres Therapeutics (NASDAQ:MCRB) is scheduled to announce Q3 earnings results on Wednesday, November 13th, before market open ...

Analysts are estimating that Seres Therapeutics will report an earnings per share (EPS) of $-0.24. Seres Therapeutics bulls ...

Prominent players in the human microbiome market are Seres Therapeutics, Inc. (US), Enterome (France), 4D pharma plc (UK), ...

On Monday, Seres Therapeutics Inc (MCRB) stock saw a decline, ending the day at $0.81 which represents a decrease of $-0.01 or -1.22% from the prior close of $0.82. The stock opened at $0.83 and ...

Chinese NEV maker Seres saw its revenue from January to September this year hit 106.63 billion yuan ($14.99 billion), up ...

On Tuesday, Seres Therapeutics Inc (MCRB) stock saw a modest uptick, ending the day at $0.77 which represents a slight increase of $0.07 or 10.00% from the prior close of $0.7. The stock opened at $0.